- Stocks
- Healthcare
- NASDAQ: MGLN

Price (delayed)

$93.32

Market cap

$2.42B

P/E Ratio

6.16

Dividend/share

N/A

EPS

$15.14

Enterprise value

$1.92B

Sector: Healthcare

Industry: Healthcare Plans

Magellan Health's quick ratio has soared by 199% from the previous quarter and by 181% YoY

The net income has soared by 185% QoQ

Magellan Health's gross profit has decreased by 40% QoQ and by 26% YoY

Magellan Health's gross margin has decreased by 32% from the previous quarter and by 26% YoY

What are the main financial stats of MGLN

Market
Valuations
Earnings

Shares outstanding

25.97M

Market cap

$2.42B

Enterprise value

$1.92B

Price to earnings (P/E)

6.16

Price to book (P/B)

1.28

Price to sales (P/S)

0.52

EV/EBIT

5.2

EV/EBITDA

3.93

EV/Sales

0.42

Revenue

$4.58B

EBIT

$368.67M

EBITDA

$487.41M

Free cash flow

$375.28M

Per share
Balance sheet
Liquidity

EPS

$15.14

Free cash flow per share

$14.66

Book value per share

$73.03

Revenue per share

$178.76

TBVPS

$93.97

Total assets

$3.36B

Total liabilities

$1.46B

Debt

$638.38M

Equity

$1.87B

Working capital

$1.42B

Debt to equity

0.34

Current ratio

2.92

Quick ratio

2.75

Net debt/EBITDA

-1.04

Margins
Efficiency
Dividend

EBITDA margin

10.6%

Gross margin

2.6%

Net margin

8.4%

Operating margin

-0.3%

Return on assets

11.5%

Return on equity

23.8%

Return on invested capital

23.1%

Return on capital employed

14.1%

Return on sales

8.1%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Magellan Health stock price performed over time

Intraday

0.13%

1 week

0.09%

1 month

-1.3%

1 year

39.01%

YTD

12.65%

QTD

12.65%

How have Magellan Health's revenue and profit performed over time

Revenue

$4.58B

Gross profit

$118.79M

Operating income

-$13.67M

Net income

$382.34M

Gross margin

2.6%

Net margin

8.4%

The net income has soared by 185% QoQ

Magellan Health's operating margin has plunged by 127% YoY and by 123% from the previous quarter

Magellan Health's operating income has shrunk by 127% YoY and by 120% QoQ

Magellan Health's gross profit has decreased by 40% QoQ and by 26% YoY

What is Magellan Health's growth rate over time

What is Magellan Health stock price valuation

P/E

6.16

P/B

1.28

P/S

0.52

EV/EBIT

5.2

EV/EBITDA

3.93

EV/Sales

0.42

MGLN's EPS has soared by 181% since the previous quarter

The stock's price to earnings (P/E) is 86% less than its 5-year quarterly average of 43.4 and 49% less than its last 4 quarters average of 12.0

MGLN's equity is up by 34% year-on-year and by 18% since the previous quarter

The P/B is 16% more than the last 4 quarters average of 1.1 but 9% less than the 5-year quarterly average of 1.4

MGLN's price to sales (P/S) is 30% higher than its 5-year quarterly average of 0.4 and 30% higher than its last 4 quarters average of 0.4

The revenue has declined by 12% since the previous quarter

How efficient is Magellan Health business performance

MGLN's ROA has soared by 180% since the previous quarter

MGLN's ROS has soared by 179% since the previous quarter

MGLN's return on invested capital has surged by 172% since the previous quarter

The company's return on equity has surged by 164% QoQ

What is MGLN's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for MGLN.

How did Magellan Health financials performed over time

The total assets is 131% more than the total liabilities

Magellan Health's quick ratio has soared by 199% from the previous quarter and by 181% YoY

Magellan Health's current ratio has soared by 59% YoY and by 40% from the previous quarter

Magellan Health's debt is 66% lower than its equity

MGLN's equity is up by 34% year-on-year and by 18% since the previous quarter

MGLN's debt to equity is down by 31% YoY and by 17% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.